Access to POEMs and Essential Evidence Plus will no longer be included in CMA membership as of Dec. 1, 2023.
Clinical Question
Is an algorithm-based approach to the treatment of staphylococcal bacteremia as effective as usual care?
Bottom line
As compared with usual care, the use of an algorithm-based treatment protocol to guide antibiotic duration for staphylococcal bacteremia led to similar success rates and a shorter duration of antibiotics, specifically for uncomplicated coagulase-negative staphylococcal bacteremia. Although the rate of serious adverse events, including mortality, was not significantly different in the 2 groups, the confidence interval was wide, with a trend of more events in the algorithm group, suggesting that the study did not have enough power to detect a true difference if it exists. 1b-
Reference
Study design: Randomized controlled trial (nonblinded)
Funding: Government
Setting: Inpatient (any location) with outpatient follow-up
Synopsis
Recommended treatment duration for staphylococcal bacteremia is based on low-quality evidence and expert opinion. In this study, patients with positive blood cultures for either Staphylococcus aureus or coagulase-negative staphylococci were randomized to algorithm-based therapy or usual care. The algorithm stated that patients with S aureus bacteremia who had uncomplicated infections (eg, defervescence within 72 hours, no indwelling devices) should be treated for 14 days, and those with complicated infections (eg, endocarditis, signs of metastatic infection) should be treated for 28 days to 42 days. For patients with coagulase-negative staphylococcal bacteremia, the algorithm stated that treatment should last from 0 to 28 days based on the complexity of the infection with 5 days of therapy recommended for uncomplicated bacteremia. Further, in the algorithm group, patients with methicillin-resistant staphylococci were treated with vancomycin or daptomycin while patients with methicillin-susceptible staphylococci were treated with an anti-staphylococcal penicillin or cefazolin. In the usual care group, the choice and duration of antibiotics were determined by the treating clinician. Patients in the 2 groups were similar: More than 80% of patients had simple or uncomplicated bacteremia, mostly with coagulase-negative staphylococci, and two-thirds were health-care–related infections. The duration of antibiotic therapy was shorter in the algorithm group (4.4 days vs 6.2 days; difference -1.8 days; 95% CI -3.1 to -0.6 days), driven by the shorter duration of treatment in patients with uncomplicated coagulase-negative staphylococcal bacteremia (5.3 days vs. 8.4 days; difference -3.1 days; -4.9 to -1.3 days). The primary outcome was clinical success rate, which was defined as clinical and microbiological resolution of bacteremia at 28 days. Clinical success occurred in 82% of the algorithm group and 81.5% of the usual care group, with a lower limit of the confidence interval of greater than -15%, which fulfills the noninferiority criteria. There was no significant difference detected in the rate of serious adverse events, but the confidence interval was wide (32.5% vs 28.3%; difference 4.2%; -3.8% to 12.2%).
Reviewer
Nita Shrikant Kulkarni, MD
Assistant Professor in Hospital Medicine
Northwestern University
Chicago, IL
Comments
Good poem
A marginal statistical difference.many statistical problems with this study, it is doubtful that this study will change anything
In my practice I always notice short course antibiotics helpful than long duration. I some times notice 3-5 days course of antibiotics is effective for URTI than 7-10 course. So really agree with that shorter duration of antibiotics has similar success rate.